470 related articles for article (PubMed ID: 28558994)
1. PPARα-independent transcriptional targets of perfluoroalkyl acids revealed by transcript profiling.
Rosen MB; Das KP; Rooney J; Abbott B; Lau C; Corton JC
Toxicology; 2017 Jul; 387():95-107. PubMed ID: 28558994
[TBL] [Abstract][Full Text] [Related]
2. Perfluoroalkyl acids-induced liver steatosis: Effects on genes controlling lipid homeostasis.
Das KP; Wood CR; Lin MT; Starkov AA; Lau C; Wallace KB; Corton JC; Abbott BD
Toxicology; 2017 Mar; 378():37-52. PubMed ID: 28049043
[TBL] [Abstract][Full Text] [Related]
3. The effects of perfluorinated chemicals on adipocyte differentiation in vitro.
Watkins AM; Wood CR; Lin MT; Abbott BD
Mol Cell Endocrinol; 2015 Jan; 400():90-101. PubMed ID: 25448844
[TBL] [Abstract][Full Text] [Related]
4. The role of mouse and human peroxisome proliferator-activated receptor-α in modulating the hepatic effects of perfluorooctane sulfonate in mice.
Su S; Billy LJ; Chang S; Gonzalez FJ; Patterson AD; Peters JM
Toxicology; 2022 Jan; 465():153056. PubMed ID: 34861291
[TBL] [Abstract][Full Text] [Related]
5. Evidence for the involvement of xenobiotic-responsive nuclear receptors in transcriptional effects upon perfluoroalkyl acid exposure in diverse species.
Ren H; Vallanat B; Nelson DM; Yeung LWY; Guruge KS; Lam PKS; Lehman-McKeeman LD; Corton JC
Reprod Toxicol; 2009 Jun; 27(3-4):266-277. PubMed ID: 19162173
[TBL] [Abstract][Full Text] [Related]
6. Perfluorooctanoic acid (PFOA) affects distinct molecular signalling pathways in human primary hepatocytes.
Buhrke T; Krüger E; Pevny S; Rößler M; Bitter K; Lampen A
Toxicology; 2015 Jul; 333():53-62. PubMed ID: 25868421
[TBL] [Abstract][Full Text] [Related]
7. Characterization of peroxisome proliferator-activated receptor alpha--independent effects of PPARalpha activators in the rodent liver: di-(2-ethylhexyl) phthalate also activates the constitutive-activated receptor.
Ren H; Aleksunes LM; Wood C; Vallanat B; George MH; Klaassen CD; Corton JC
Toxicol Sci; 2010 Jan; 113(1):45-59. PubMed ID: 19850644
[TBL] [Abstract][Full Text] [Related]
8. Evaluating the additivity of perfluoroalkyl acids in binary combinations on peroxisome proliferator-activated receptor-α activation.
Wolf CJ; Rider CV; Lau C; Abbott BD
Toxicology; 2014 Feb; 316():43-54. PubMed ID: 24374136
[TBL] [Abstract][Full Text] [Related]
9. Toxicogenomic dissection of the perfluorooctanoic acid transcript profile in mouse liver: evidence for the involvement of nuclear receptors PPAR alpha and CAR.
Rosen MB; Lee JS; Ren H; Vallanat B; Liu J; Waalkes MP; Abbott BD; Lau C; Corton JC
Toxicol Sci; 2008 May; 103(1):46-56. PubMed ID: 18281256
[TBL] [Abstract][Full Text] [Related]
10. Developmental toxicity of perfluorononanoic acid in mice.
Das KP; Grey BE; Rosen MB; Wood CR; Tatum-Gibbs KR; Zehr RD; Strynar MJ; Lindstrom AB; Lau C
Reprod Toxicol; 2015 Jan; 51():133-44. PubMed ID: 25543169
[TBL] [Abstract][Full Text] [Related]
11. Transcription of genes involved in fat metabolism in chicken embryos exposed to the peroxisome proliferator-activated receptor alpha (PPARα) agonist GW7647 or to perfluorooctane sulfonate (PFOS) or perfluorooctanoic acid (PFOA).
Strömqvist M; Olsson JA; Kärrman A; Brunström B
Comp Biochem Physiol C Toxicol Pharmacol; 2012 Jun; 156(1):29-36. PubMed ID: 22465071
[TBL] [Abstract][Full Text] [Related]
12. Activation of mouse and human peroxisome proliferator-activated receptor alpha by perfluoroalkyl acids of different functional groups and chain lengths.
Wolf CJ; Takacs ML; Schmid JE; Lau C; Abbott BD
Toxicol Sci; 2008 Nov; 106(1):162-71. PubMed ID: 18713766
[TBL] [Abstract][Full Text] [Related]
13. Activation of mouse and human peroxisome proliferator-activated receptors (alpha, beta/delta, gamma) by perfluorooctanoic acid and perfluorooctane sulfonate.
Takacs ML; Abbott BD
Toxicol Sci; 2007 Jan; 95(1):108-17. PubMed ID: 17047030
[TBL] [Abstract][Full Text] [Related]
14. Toxic effects of fumonisin in mouse liver are independent of the peroxisome proliferator-activated receptor alpha.
Voss KA; Liu J; Anderson SP; Dunn C; Miller JD; Owen JR; Riley RT; Bacon CW; Corton JC
Toxicol Sci; 2006 Jan; 89(1):108-19. PubMed ID: 16221962
[TBL] [Abstract][Full Text] [Related]
15. Gene profiling in the livers of wild-type and PPARalpha-null mice exposed to perfluorooctanoic acid.
Rosen MB; Abbott BD; Wolf DC; Corton JC; Wood CR; Schmid JE; Das KP; Zehr RD; Blair ET; Lau C
Toxicol Pathol; 2008 Jun; 36(4):592-607. PubMed ID: 18467677
[TBL] [Abstract][Full Text] [Related]
16. Gene Expression Profiling in Wild-Type and PPARα-Null Mice Exposed to Perfluorooctane Sulfonate Reveals PPARα-Independent Effects.
Rosen MB; Schmid JR; Corton JC; Zehr RD; Das KP; Abbott BD; Lau C
PPAR Res; 2010; 2010():. PubMed ID: 20936131
[TBL] [Abstract][Full Text] [Related]
17. Overlapping transcriptional programs regulated by the nuclear receptors peroxisome proliferator-activated receptor alpha, retinoid X receptor, and liver X receptor in mouse liver.
Anderson SP; Dunn C; Laughter A; Yoon L; Swanson C; Stulnig TM; Steffensen KR; Chandraratna RA; Gustafsson JA; Corton JC
Mol Pharmacol; 2004 Dec; 66(6):1440-52. PubMed ID: 15371561
[TBL] [Abstract][Full Text] [Related]
18. Alteration of Bile Acid and Cholesterol Biosynthesis and Transport by Perfluorononanoic Acid (PFNA) in Mice.
Zhang Y; Zhang Y; Klaassen CD; Cheng X
Toxicol Sci; 2018 Mar; 162(1):225-233. PubMed ID: 29112762
[TBL] [Abstract][Full Text] [Related]
19. The effects of perfluorooctanoate on high fat diet induced non-alcoholic fatty liver disease in mice.
Li X; Wang Z; Klaunig JE
Toxicology; 2019 Mar; 416():1-14. PubMed ID: 30711707
[TBL] [Abstract][Full Text] [Related]
20. Comparative hepatotoxicity of 6:2 fluorotelomer carboxylic acid and 6:2 fluorotelomer sulfonic acid, two fluorinated alternatives to long-chain perfluoroalkyl acids, on adult male mice.
Sheng N; Zhou X; Zheng F; Pan Y; Guo X; Guo Y; Sun Y; Dai J
Arch Toxicol; 2017 Aug; 91(8):2909-2919. PubMed ID: 28032147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
